Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Cancer Metastatic × Liposomes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 7 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 2 Leukemia, Monocytic, Acute 2 Sarcoma, Kaposi 1 Rectal Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 HIV Infections 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Cancer Metastatic 1 Acquired Immunodeficiency Syndrome 1

Interventions

Fulvestrant 5 Letrozole 3 ribociclib 2 exemestane 2 dalpiciclib 2 apatinib 2 Gemcitabine 2 Capecitabine 2 Anastrozole 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 palbociclib 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Vinorelbine 1 Trastuzumab 1 Tamoxifen 1 Paclitaxel 1 Liposomes 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03328884 2025-04-23

Phenomenal

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡